|
1
|
Neville MC, McFadden TB and Forsyth I:
Hormonal regulation of mammary differentiation and milk secretion.
J Mammary Gland Biol Neoplasia. 7:49–66. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jensen EV, Cheng G, Palmieri C, Saji S,
Mäkelä S, Van Noorden S, Wahlström T, Warner M, Coombes RC and
Gustafsson JA: Estrogen receptors and proliferation markers in
primary and recurrent breast cancer. Proc Natl Acad Sci USA.
98:15197–15202. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lanari C and Molinolo AA: Progesterone
receptors - animal models and cell signalling in breast cancer.
Diverse activation pathways for the progesterone receptor: possible
implications for breast biology and cancer. Breast Cancer Res.
4:240–243. 2002. View
Article : Google Scholar
|
|
4
|
Clevenger CV, Furth PA, Hankinson SE and
Schuler LA: The role of prolactin in mammary carcinoma. Endocr Rev.
24:1–27. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Frontini L, Lissoni P, Vaghi M, Perego MS,
Pescia S, Ardizzoia A and Gardani G: Enhancement of the efficacy of
weekly low-dose taxotere by the long acting anti-prolactinemic drug
cabergoline in pretreated metastatic breast cancer. Anticancer Res.
24:4223–4226. 2004.PubMed/NCBI
|
|
6
|
Shen Q, Lantvit DD, Lin Q, Li Y, Christov
K, Wang Z, Unterman TG, Mehta RG and Swanson SM: Advanced rat
mammary cancers are growth hormone dependent. Endocrinology.
148:4536–4544. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Angelousi AG, Anagnostou VK, Stamatakos
MK, Georgiopoulos GA and Kontzoglou KC: Mechanisms in
endocrinology: primary HT and risk for breast cancer: a systematic
review and meta-analysis. Eur J Endocrinol. 166:373–381. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cristofanilli M, Yamamura Y, Kau SW,
Bevers T, Strom S, Patangan M, Hsu L, Krishnamurthy S, Theriault RL
and Hortobagyi GN: Thyroid hormone and breast carcinoma. Primary
hypothyroidism is associated with a reduced incidence of primary
breast carcinoma. Cancer. 103:1122–1128. 2005.PubMed/NCBI
|
|
9
|
Barrera-Hernandez G, Park KS, Dace A, Zhan
Q and Cheng SY: Thyroid hormone-induced cell proliferation in GC
cells is mediated by changes in G1 cyclin/cyclin-dependent kinase
levels and activity. Endocrinology. 140:5267–5274. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jeong YJ, Bong JG, Park SH, Choi JH and Oh
HK: Expression of leptin, leptin receptor, adiponectin, and
adiponectin receptor in ductal carcinoma in situ and invasive
breast cancer. J Breast Cancer. 14:96–103. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Goodman AD, Hoekstra SJ and Marsh PS:
Effects of hypothyroidism on the induction and growth of mammary
cancer induced by 7,12-dimethylbenz(a)anthracene in the rat. Cancer
Res. 40:2336–2342. 1980.PubMed/NCBI
|
|
12
|
Giovambattista A, Piermaria J, Suescun MO,
Calandra RS, Gaillard RC and Spinedi E: Direct effect of ghrelin on
leptin production by cultured rat white adipocytes. Obesity.
14:19–27. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Russo J and Russo IH: Atlas and histologic
classification of tumors of the rat mammary gland. J Mammary Gland
Biol Neoplasia. 5:187–200. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
López-Fontana CM, Maselli ME, Salicioni AM
and Carón RW: The inhibitory effect of progesterone on lactogenesis
during pregnancy is already evident by mid- to late gestation in
rodents. Reprod Fertil Dev. 24:704–714. 2012.PubMed/NCBI
|
|
15
|
Cuello-Carrión FD and Ciocca DR: Improved
detection of apoptotic cells using a modified in situ TUNEL
technique. J Histochem Cytochem. 47:837–839. 1999.PubMed/NCBI
|
|
16
|
Vazquez-Prieto MA, Renna NF, Diez ER,
Cacciamani V, Lembo C and Miatello RM: Effect of red wine on
adipocytokine expression and vascular alterations in fructose-fed
rats. Am J Hypertens. 24:234–240. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ito K and Maruchi N: Breast cancer in
patients with Hashimoto’s thyroiditis. Lancet. 2:1119–1121.
1975.
|
|
18
|
Shering SG, Zbar AP, Moriarty M, McDermott
EW, O’Higgins NJ and Smyth PP: Thyroid disorders and breast cancer.
Eur J Cancer Prev. 5:504–506. 1996.
|
|
19
|
Nogueira CR and Brentani MM:
Triiodothyronine mimics the effects of estrogen in breast cancer
cell lines. J Steroid Biochem Mol Biol. 59:271–279. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Brinton LA, Hoffman DA, Hoover R and
Fraumeni JF Jr: Relationship of thyroid disease and use of thyroid
supplements to breast cancer risk. J Chronic Dis. 37:877–893. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Martinez-Iglesias O, Garcia-Silva S,
Regadera J and Aranda A: Hypothyroidism enhances tumor invasiveness
and metastasis development. PLoS One. 4:e64282009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hardefeldt PJ, Eslick GD and Edirimanne S:
Benign thyroid disease is associated with breast cancer: a
meta-analysis. Breast Cancer Res Treat. 133:1169–1177. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kapdi CC and Wolfe JN: Breast cancer.
Relationship to thyroid supplements for hypothyroidism. JAMA.
236:1124–1127. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mustacchi P and Greenspan F: Thyroid
supplementation for hypothyroidism. An latrogenic cause of breast
cancer? JAMA. 237:1446–1447. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Saraiva PP, Figueiredo NB, Padovani CR,
Brentani MM and Nogueira CR: Profile of thyroid hormones in breast
cancer patients. Braz J Med Biol Res. 38:761–765. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Raccurt M, Lobie PE, Moudilou E,
Garcia-Caballero T, Frappart L, Morel G and Mertani HC: High
stromal and epithelial human gh gene expression is associated with
proliferative disorders of the mammary gland. J Endocrinol.
175:307–318. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kleinberg DL, Wood TL, Furth PA and Lee
AV: Growth hormone and insulin-like growth factor-I in the
transition from normal mammary development to preneoplastic mammary
lesions. Endocr Rev. 30:51–74. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Thijssen JH: On the possible role of
mammary-derived growth hormone in human breast cancer. Maturitas.
65(Suppl 1): S13–S16. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hapon MB, Gamarra-Luques C and Jahn GA:
Short term hypothyroidism affects ovarian function in the cycling
rat. Reprod Biol Endocrinol. 8:142010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rinaldi S, Toniolo P, Muti P, Lundin E,
Zeleniuch-Jacquotte A, Arslan A, Micheli A, Lenner P, Dossus L,
Krogh V, Shore RE, Koenig KL, Riboli E, Stattin P, Berrino F,
Hallmans G, Lukanova A and Kaaks R: IGF-I, IGFBP-3 and breast
cancer in young women: a pooled re-analysis of three prospective
studies. Eur J Cancer Prev. 14:493–496. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kaulsay KK, Mertani HC, Törnell J, Morel
G, Lee KO and Lobie PE: Autocrine stimulation of human mammary
carcinoma cell proliferation by human growth hormone. Exp Cell Res.
250:35–50. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mukhina S, Mertani HC, Guo K, Lee KO,
Gluckman PD and Lobie PE: Phenotypic conversion of human mammary
carcinoma cells by autocrine human growth hormone. Proc Natl Acad
Sci USA. 101:15166–15171. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Russo J, Lynch H and Russo IH: Mammary
gland architecture as a determining factor in the susceptibility of
the human breast to cancer. Breast J. 7:278–291. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tan J, Buache E, Chenard MP, Dali-Youcef N
and Rio MC: Adipocyte is a non-trivial, dynamic partner of breast
cancer cells. Int J Dev Biol. 55:851–859. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Neville MC, Medina D, Monks J and Hovey
RC: The mammary fat pad. J Mammary Gland Biol Neoplasia. 3:109–116.
1998. View Article : Google Scholar
|
|
36
|
Petersen OW, Rønnov-Jessen L, Weaver VM
and Bissell MJ: Differentiation and cancer in the mammary gland:
shedding light on an old dichotomy. Adv Cancer Res. 75:135–161.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Vonderhaar BK and Greco AE: Effect of
thyroid status on development of spontaneous mammary tumors in
primiparous C3H mice. Cancer Res. 42:4553–4561. 1982.PubMed/NCBI
|
|
38
|
Vonderhaar BK and Greco AE:
Lobulo-alveolar development of mouse mammary glands is regulated by
thyroid hormones. Endocrinology. 104:409–418. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Knight BB, Oprea-Ilies GM, Nagalingam A,
Yang L, Cohen C, Saxena NK and Sharma D: Survivin upregulation,
dependent on leptin-EGFR-Notch1 axis, is essential for
leptin-induced migration of breast carcinoma cells. Endocr Relat
Cancer. 18:413–428. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhou W, Guo S and Gonzalez-Perez RR:
Leptin pro-angiogenic signature in breast cancer is linked to IL-1
signalling. Br J Cancer. 104:128–137. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mantzoros CS: The role of leptin in human
obesity and disease: a review of current evidence. Ann Intern Med.
130:671–680. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Valcavi R, Zini M, Peino R, Casanueva FF
and Dieguez C: Influence of thyroid status on serum immunoreactive
leptin levels. J Clin Endocrinol Metab. 82:1632–1634.
1997.PubMed/NCBI
|
|
43
|
Sreenan S, Caro JF and Refetoff S: Thyroid
dysfunction is not associated with alterations in serum leptin
levels. Thyroid. 7:407–409. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Leonhardt U, Ritzel U, Schäfer G, Becker W
and Ramadori G: Serum leptin levels in hypo- and hyperthyroidism. J
Endocrinol. 157:75–79. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Housa D, Housová J, Vernerová Z and
Haluzik M: Adipocytokines and cancer. Physiol Res. 55:233–244.
2006.
|
|
46
|
Rose DP, Gilhooly EM and Nixon DW: Adverse
effects of obesity on breast cancer prognosis, and the biological
actions of leptin (Review). Int J Oncol. 21:1285–1292.
2002.PubMed/NCBI
|
|
47
|
Artwohl M, Roden M, Hölzenbein T,
Freudenthaler A, Waldhäusl W and Baumgartner-Parzer SM: Modulation
by leptin of proliferation and apoptosis in vascular endothelial
cells. Int J Obes Relat Metab Disord. 26:577–580. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Pasqualini JR: Breast cancer and steroid
metabolizing enzymes: the role of progestogens. Maturitas. 65(Suppl
1): S17–S21. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Bolton JL and Thatcher GR: Potential
mechanisms of estrogen quinone carcinogenesis. Chem Res Toxicol.
21:93–101. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Goepfert TM, McCarthy M, Kittrell FS,
Stephens C, Ullrich RL, Brinkley BR and Medina D: Progesterone
facilitates chromosome instability (aneuploidy) in p53 null normal
mammary epithelial cells. FASEB J. 14:2221–2229. 2000. View Article : Google Scholar : PubMed/NCBI
|
